3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Lymphoid
9
Other hematologic neoplasm
7
Plasma cell
2
Gastrointestinal
2
CNS
2
Breast
2
Classical hematology
1
Conditions
Colorectal Neoplasms
4606
Pancreatic Neoplasms
2845
Carcinoma, Hepatocellular
2480
Stomach Neoplasms
2330
Colonic Neoplasms
1791
Rectal Neoplasms
1720
Esophageal Neoplasms
1376
Liver Neoplasms
921
Neoplasms
915
Breast Neoplasms
839
Neoplasm Metastasis
765
Carcinoma, Non-Small-Cell Lung
707
Cholangiocarcinoma
587
Lung Neoplasms
557
Ovarian Neoplasms
535
Esophageal Squamous Cell Carcinoma
514
Gastrointestinal Neoplasms
495
Melanoma
381
Prostatic Neoplasms
373
Biliary Tract Neoplasms
373
Head and Neck Neoplasms
303
Uterine Cervical Neoplasms
288
Carcinoma, Renal Cell
284
Adenocarcinoma Of Esophagus
273
Squamous Cell Carcinoma of Head and Neck
264
Sarcoma
264
Gastrointestinal Stromal Tumors
252
Endometrial Neoplasms
235
Urinary Bladder Neoplasms
226
Gallbladder Neoplasms
225
Interventions
Influenza Vaccines
2
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Influenza, Human
×
Gastrointestinal
×
Clear all
NCT06124131
2025-05-04
BENEFIT-C
Tulane University
Phase NA
Completed
50 enrolled
15 charts
NCT05116917
2024-05-28
INFLUENCE
Herlev Hospital
Phase 2
Terminated
19 enrolled